Welcome to our dedicated page for Victory Square news (Ticker: VSQTF), a resource for investors and traders seeking the latest updates and insights on Victory Square stock.
Victory Square Technologies Inc. (VSQTF) generates frequent news as a venture builder with a diversified portfolio of early-stage technology companies. Company updates often combine financial results with detailed commentary on portfolio performance, particularly in digital health, artificial intelligence, Web3, gaming, climate tech, and pet wellness.
News releases commonly cover quarterly and annual financial results, including adjusted revenue, GAAP revenue, gross margin, and adjusted EBITDA, along with management’s discussion of portfolio momentum and capital allocation. Investors can read about developments such as revenue growth, profitability trends, and the impact of monetizing specific assets.
Another major theme in Victory Square’s news flow is portfolio company progress. Regular updates highlight Hydreight Technologies’ expansion as a digital health platform, the evolution of the VSDHOne infrastructure, Insu Therapeutics’ work on oral insulin delivery, Pawsible Ventures’ pet health initiatives, XR Immersive Tech’s move into health-related IP, and SafeTest’s digital health activities in Brazil. The company also reports on transactions involving holdings like BlockX and performance milestones at GameOn.
Corporate actions and strategic initiatives are also featured. Victory Square has announced a Normal Course Issuer Bid to repurchase shares, described a $10 million digital health and longevity accelerator, and provided NAV-focused corporate updates and investor webinar details. For investors tracking VSQTF, this news page offers a consolidated view of how Victory Square’s portfolio and strategy evolve over time, including financial metrics, sector-specific developments, and capital recycling decisions.
Victory Square Health has received FDA permission to market its Safetest 15 Minute Rapid Test for Covid-19 under Emergency Use Authorization (EUA) as of October 9, 2020. The rapid test boasts a 96.6% sensitivity and provides results in just 15 minutes through a simple blood sample. This approval complements the earlier Elisa Test EUA received on August 25, 2020. With over 7.8 million Covid-19 cases reported in the U.S., the test aims to facilitate quick screening and help curb virus spread. The test is currently under review by Health Canada.
Victory Square Technologies Inc. (CSE:VST, OTC:VSQTF) announced an expanded shareholder communications initiative aimed at enhancing transparency regarding its business plans and growth strategy. CEO Shafin Diamond Tejani emphasized the importance of providing relevant information to shareholders, especially given the rapid growth of its portfolio companies. The company engaged Electrik Dojo, LLC for digital marketing and will participate in investor forums to disseminate information. Recent updates include partnerships for Covid-19 testing resources and production increases, reflecting active company developments.